
CR Pharmaceutical Becomes Constituent of MSCI China Index Once Again
HONG KONG, Nov 14, 2022 – (ACN Newswire via SEAPRWire.com) – China Resources Pharmaceutical Group Limited (“CR Pharmaceutical” or the “Group”) (stock code: 3320) has announced that the Group will once again be included as a constituent stock of the MSCI China Index, which will become effective after the market close on 30 November 2022.... » read more